Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olga Vornicova

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Expert Opinion on Investigational Drugs|March 19, 2016
Investigational therapies for Ewing sarcoma: a search without a clear findingOlga Vornicova, Gil Bar-Sela
Cancer Chemotherapy and Pharmacology|August 15, 2019
A pilot study of first-line olaratumab, doxorubicin and ifosfamide in patients with metastatic soft tissue sarcomaOlga Vornicova, Nissim Haim, Gil Bar-Sela
International Journal of Molecular Sciences|January 21, 2023
Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous CancersPavlina Spiliopoulou, Olga Vornicova, Sofia Genta, et al.
World Journal of Clinical Cases|September 26, 2022
Ectopic Cushing's syndrome in a patient with metastatic Merkel cell carcinoma: A case reportAvraham Ishay, Elia Touma, Olga Vornicova, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 5, 2020
The perception of Israeli oncology staff members regarding advance care planningGil Bar-Sela, Shlomit Bagon, Inbal Mitnik, et al.
Oncotarget|February 22, 2018
Prognostic significance of heparanase expression in primary and metastatic breast carcinomaOlga Vornicova, Inna Naroditsky, Ilanit Boyango, et al.
Journal of Geriatric Oncology|May 29, 2021
The perception and attitudes of Israeli cancer patients regarding advance care planningGil Bar-Sela, Shlomit Bagon, Inbal Mitnik, et al.
Surgical Oncology Clinics of North America|June 17, 2022
Leiomyosarcoma: Current Clinical Management and Future HorizonsNicolas Devaud, Olga Vornicova, Albiruni R Abdul Razak, et al.
Oncotarget|October 13, 2016
The prognostic significance of heparanase expression in metastatic melanomaOlga Vornicova, Ilanit Boyango, Sari Feld, et al.
Targeted Oncology|June 18, 2024
Safety and Preliminary Efficacy of Once-Weekly Split-Dose Selinexor in Soft Tissue Sarcoma: Results of the Phase Ib METSSAR Clinical TrialAbdulazeez Salawu, Eoghan R Malone, Esmail Al-Ezzi, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Expert Opinion on Investigational Drugs|March 19, 2016
Investigational therapies for Ewing sarcoma: a search without a clear findingOlga Vornicova, Gil Bar-Sela
Cancer Chemotherapy and Pharmacology|August 15, 2019
A pilot study of first-line olaratumab, doxorubicin and ifosfamide in patients with metastatic soft tissue sarcomaOlga Vornicova, Nissim Haim, Gil Bar-Sela
International Journal of Molecular Sciences|January 21, 2023
Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous CancersPavlina Spiliopoulou, Olga Vornicova, Sofia Genta, et al.
World Journal of Clinical Cases|September 26, 2022
Ectopic Cushing's syndrome in a patient with metastatic Merkel cell carcinoma: A case reportAvraham Ishay, Elia Touma, Olga Vornicova, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 5, 2020
The perception of Israeli oncology staff members regarding advance care planningGil Bar-Sela, Shlomit Bagon, Inbal Mitnik, et al.
Oncotarget|February 22, 2018
Prognostic significance of heparanase expression in primary and metastatic breast carcinomaOlga Vornicova, Inna Naroditsky, Ilanit Boyango, et al.
Journal of Geriatric Oncology|May 29, 2021
The perception and attitudes of Israeli cancer patients regarding advance care planningGil Bar-Sela, Shlomit Bagon, Inbal Mitnik, et al.
Surgical Oncology Clinics of North America|June 17, 2022
Leiomyosarcoma: Current Clinical Management and Future HorizonsNicolas Devaud, Olga Vornicova, Albiruni R Abdul Razak, et al.
Oncotarget|October 13, 2016
The prognostic significance of heparanase expression in metastatic melanomaOlga Vornicova, Ilanit Boyango, Sari Feld, et al.
Targeted Oncology|June 18, 2024
Safety and Preliminary Efficacy of Once-Weekly Split-Dose Selinexor in Soft Tissue Sarcoma: Results of the Phase Ib METSSAR Clinical TrialAbdulazeez Salawu, Eoghan R Malone, Esmail Al-Ezzi, et al.
Pageof 2